French Transparency Commission Recognises Efficacy of Zonegran® (zonisamide) Monotherapy

Eisai Europe Limited [Pressemappe]
Hatfield, England (ots/PRNewswire) – Transparency advice for Zonegran(R) (zonisamide) monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy, has been published by the … Lesen Sie hier weiter…